Mansukh Mandaviya, the Union Health Minister, inaugurated iNCOVACC on Republic Day and praised it as a glorious tribute to the call for Atmanirbhar Bharat despite the fact that more than 65% of the vaccinations distributed worldwide come from India. This demonstrates the nation’s skill as a trustworthy manufacturer of vaccines. Since the start of the pandemic, the Union Government has provided Covid vaccinations, medications, and equipment to more than 150 countries through the Vaccine Maitri Programme, which has significantly aided India in gaining respect around the world.
The fact that the nation has not experienced another disastrous wave since the one that claimed tens of thousands of lives in April and May 2021 is primarily because to the effectiveness and safety of our Covid vaccines. Although Covid has lost its lustre in India, its return in nations like China, Japan, and South Korea makes it imperative not to let oneu2019s guard down.
Video Courtesy: ANI News
The creation of efficient vaccines for Covid-19 has risen to the top of the priority list for many pharmaceutical companies and medical research organisations, according to a joint statement from the World Health Organization and the International Coalition of Medicines Regulatory Authorities from the previous year.
Over the past two years, Indian pharmaceutical companies have been at the forefront of these vital R&D initiatives. The iNCOVACC rollout is a much-needed breath of fresh air for the Indian pharmaceutical industry, which has spent much of recent months in the news for the wrong reasons after around 70 children’s deaths in the Gambia and at least 20 in Uzbekistan were linked to the use of cough syrups produced by Indian companies. If its pricing and accessibility are addressed, it is believed that the intranasal vaccination will allow the government to expand coverage of the booster dose and encourage people to shed their hesitancy.
In the comment section below, let us know what you think of India’s accomplishment.
